Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.251ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.251ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.251NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.144ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.144ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.144NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.288ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.288ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.288ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.288NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.249ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.249ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.249NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.378ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.378ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.378NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.97ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.97NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.439ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.439ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.439ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.439NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.408ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.408ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.408ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.408NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.256ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.256ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used